{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T20:32:52Z","timestamp":1776285172001,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.nmd.2021.03.004","type":"journal-article","created":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T03:35:27Z","timestamp":1616470527000},"page":"546-550","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Ranolazine-induced lipid storage myopathy presenting with respiratory failure and head drop"],"prefix":"10.1016","volume":"31","author":[{"given":"Pritikanta","family":"Paul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rocio","family":"Vazquez Do Campo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teerin","family":"Liewluck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elie","family":"Naddaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2021.03.004_bib0001","article-title":"Ranolazine: a contemporary review","volume":"5","author":"Erin","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.nmd.2021.03.004_bib0002","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2174\/157489007779606095","article-title":"Ranolazine, a partial fatty acid oxidation inhibitor, its potential benefit in angina and other cardiovascular disorders","volume":"2","author":"Bhandari","year":"2007","journal-title":"Recent Pat Cardiovasc Drug Discov"},{"key":"10.1016\/j.nmd.2021.03.004_bib0003","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jns.2014.10.037","article-title":"Myopathy during treatment with the antianginal drug ranolazine","volume":"347","author":"Kassardjian","year":"2014","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.nmd.2021.03.004_bib0004","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/CND.0b013e31828525a5","article-title":"Ranolazine-induced myopathy in a patient on chronic statin therapy","volume":"14","author":"Correa","year":"2013","journal-title":"J Clin Neuromuscul Dis"},{"key":"10.1016\/j.nmd.2021.03.004_bib0005","first-page":"264","article-title":"Multiple drug interactions in a renal transplant patient leading to simvastatin-induced rhabdomyolysis: a case report","volume":"10","author":"Rifkin","year":"2008","journal-title":"Medscape J Med"},{"key":"10.1016\/j.nmd.2021.03.004_bib0006","first-page":"1829","article-title":"Rhabdomyolysis in a patient receiving ranolazine and simvastatin","volume":"67","author":"Hylton","year":"2010","journal-title":"Am J Health Pharm AJHP Off J Am Soc Heal Pharm"},{"key":"10.1016\/j.nmd.2021.03.004_bib0007","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/mus.25602","article-title":"Hereditary myopathies with early respiratory insufficiency in adults","volume":"56","author":"Naddaf","year":"2017","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2021.03.004_bib0008","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.nmd.2019.12.001","article-title":"Myopathies presenting with head drop: clinical spectrum and treatment outcomes","volume":"30","author":"Alhammad","year":"2020","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2021.03.004_bib0009","first-page":"e2832-","article-title":"Ranolazine-induced elevation of creatinine kinase in the absence of statin usage","volume":"10","author":"Dein","year":"2018","journal-title":"Cureus"},{"key":"10.1016\/j.nmd.2021.03.004_bib0010","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s11910-010-0154-y","article-title":"Lipid storage myopathy","volume":"11","author":"Liang","year":"2011","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.nmd.2021.03.004_bib0011","first-page":"207","article-title":"Neutral lipid storage disease with myopathy and dropped head syndrome","volume":"58","author":"Garcia","year":"2018","journal-title":"J Clin Neurosci Off J Neurosurg Soc Australas"},{"key":"10.1016\/j.nmd.2021.03.004_bib0012","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.nmd.2017.08.004","article-title":"Fatty acid oxidation defects presenting as primary myopathy and prominent dropped head syndrome","volume":"27","author":"Vengalil","year":"2017","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2021.03.004_bib0013","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/mus.24552","article-title":"Fulminant lipid storage myopathy due to multiple acyl-coenzyme a dehydrogenase deficiency","volume":"52","author":"Whitaker","year":"2015","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2021.03.004_bib0014","doi-asserted-by":"crossref","DOI":"10.1212\/01.wnl.0000194241.35115.7c","article-title":"Coenzyme Q10 deficiency and isolated myopathy","volume":"66","author":"Horvath","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2021.03.004_bib0015","first-page":"85\u201489","article-title":"Mitochondrial alterations in muscle biopsies of patients on statin therapy","volume":"36","author":"Gambelli","year":"2004","journal-title":"J Submicrosc Cytol Pathol"},{"key":"10.1016\/j.nmd.2021.03.004_bib0016","doi-asserted-by":"crossref","first-page":"581","DOI":"10.7326\/0003-4819-137-7-200210010-00009","article-title":"Statin-associated myopathy with normal creatine kinase levels","volume":"137","author":"Phillips","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.nmd.2021.03.004_bib0017","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3390\/jcm6080075","article-title":"Statins, muscle disease and mitochondria","volume":"6","author":"Ramachandran","year":"2017","journal-title":"J Clin Med"},{"key":"10.1016\/j.nmd.2021.03.004_bib0018","first-page":"323","article-title":"Drug interactions with HMG-CoA reductase inhibitors (statins): the importance of CYP enzymes, transporters and pharmacogenetics","volume":"11","author":"Neuvonen","year":"2010","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.nmd.2021.03.004_bib0019","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2165\/00003088-200645050-00003","article-title":"Clinical pharmacokinetics of ranolazine","volume":"45","author":"Jerling","year":"2006","journal-title":"Clin Pharmacokinet"},{"issue":"4","key":"10.1016\/j.nmd.2021.03.004_bib0020","doi-asserted-by":"crossref","first-page":"iv6","DOI":"10.1136\/hrt.2005.078790","article-title":"Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazine","volume":"92","author":"Belardinelli","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.nmd.2021.03.004_bib0021","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/mus.20567","article-title":"Genetic risk factors associated with lipid-lowering drug-induced myopathies","volume":"34","author":"Vladutiu","year":"2006","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2021.03.004_bib0022","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00439-008-0521-9","article-title":"The ACADS gene variation spectrum in 114 patients with short-chain acyl-CoA dehydrogenase (SCAD) deficiency is dominated by missense variations leading to protein misfolding at the cellular level","volume":"124","author":"Pedersen","year":"2008","journal-title":"Hum Genet"},{"key":"10.1016\/j.nmd.2021.03.004_bib0023","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1096-7192(03)00034-9","article-title":"The frequency of short-chain acyl-CoA dehydrogenase gene variants in the US population and correlation with the C4-acylcarnitine concentration in newborn blood spots","volume":"78","author":"Nagan","year":"2003","journal-title":"Mol Genet Metab"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896621000687?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896621000687?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:10:18Z","timestamp":1760775018000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896621000687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0960896621000687"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2021.03.004","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ranolazine-induced lipid storage myopathy presenting with respiratory failure and head drop","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2021.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}